VRNA logo

Verona Pharma (VRNA) Depreciation And Amortization

Annual D&A

$1.06 M
+$381.00 K+56.28%

December 31, 2024

Summary

Performance

1-Year Change

+56.28%

3-Year Change

+68.2%

5-Year Change

+107.45%

15-Year Change

+536.58%

VRNA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.55%
VRNA annual depreciation & amortization is higher than 39.55% of companies in Healthcare sector

High & Low

All-time High

$1.06 M
VRNA annual depreciation & amortization is currently at an all-time high

3-Year Low

$629.00 K
VRNA annual depreciation & amortization is currently +68.20% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
VRNA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
VRNA next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$193.31 M
VRNA annual total expenses is $193.31 million

Annual Operating Expenses

$190.72 M
VRNA annual total operating expenses is $190.72 million

Annual Cost Of Goods Sold

$2.58 M
VRNA annual cost of goods sold is $2.58 million

Annual Interest Expense

$23.54 M
VRNA annual interest expense is $23.54 million

Quarterly D&A

$259.00 K
-$7000.00-2.63%

December 31, 2024

Summary

Performance

3-Month Change

-2.63%

1-Year Change

+24.52%

3-Year Change

+24.52%

5-Year Change

+24.52%

VRNA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.59%
VRNA quarterly depreciation & amortization is higher than 38.59% of companies in Healthcare sector

High & Low

All-time High

$270.00 K
VRNA quarterly depreciation & amortization is currently -4.07% below its historical high of $270.00 thousand

3-Year Low

$151.00 K
VRNA quarterly depreciation & amortization is currently +71.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

Related metrics

Quarterly Total Expenses

$54.44 M
VRNA quarterly total expenses is $54.44 million

Quarterly Operating Expenses

$52.40 M
VRNA quarterly total operating expenses is $52.40 million

Quarterly Cost Of Goods Sold

$2.04 M
VRNA quarterly cost of goods sold is $2.04 million

Quarterly Interest Expense

$10.32 M
VRNA quarterly interest expense is $10.32 million

TTM D&A

$1.06 M
+$51.00 K+5.06%

December 31, 2024

Summary

Performance

3-Month Change

+5.06%

1-Year Change

+56.28%

3-Year Change

+56.28%

5-Year Change

+56.28%

VRNA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.87%
VRNA TTM depreciation & amortization is higher than 38.87% of companies in Healthcare sector

High & Low

All-time High

$1.06 M
VRNA TTM depreciation & amortization is currently at an all-time high

3-Year Low

$620.00 K
VRNA TTM depreciation & amortization is currently +70.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

Related metrics

Annual Total Expenses

$193.31 M
VRNA annual total expenses is $193.31 million

Annual Operating Expenses

$190.72 M
VRNA annual total operating expenses is $190.72 million

TTM Cost Of Goods Sold

$2.58 M
VRNA TTM cost of goods sold is $2.58 million

TTM Interest Expense

$23.54 M
VRNA TTM interest expense is $23.54 million

VRNA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.3%+24.5%+56.3%
3 y3 years+68.2%+24.5%+56.3%
5 y5 years+107.5%+24.5%+56.3%

VRNA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+68.2%-4.1%+71.5%at high+70.7%
5 y5-yearat high+107.5%-4.1%+298.5%at high+107.5%
alltimeall timeat high>+9999.0%-4.1%+1195.0%at high+5190.0%

Verona Pharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$1.06 M(+56.3%)
$259.00 K(-2.6%)
$1.06 M(+5.1%)
Sep 2024
-
$266.00 K(-1.5%)
$1.01 M(+12.4%)
Jun 2024
-
$270.00 K(+2.7%)
$896.00 K(+14.4%)
Mar 2024
-
$263.00 K(+26.4%)
$783.00 K(+15.7%)
Dec 2023
$677.00 K(+6.4%)
$208.00 K(+34.2%)
$677.00 K(+9.2%)
Sep 2023
-
$155.00 K(-1.3%)
$620.00 K(-0.3%)
Jun 2023
-
$157.00 K(0.0%)
$622.00 K(-1.3%)
Mar 2023
-
$157.00 K(+4.0%)
$630.00 K(-0.9%)
Dec 2022
$636.00 K(+1.1%)
$151.00 K(-3.8%)
$636.00 K(-1.7%)
Sep 2022
-
$157.00 K(-4.8%)
$647.00 K(-0.8%)
Jun 2022
-
$165.00 K(+1.2%)
$652.00 K(+2.0%)
Mar 2022
-
$163.00 K(+0.6%)
$639.00 K(+1.6%)
Dec 2021
$629.00 K(+1.0%)
$162.00 K(0.0%)
$629.00 K(+1.8%)
Sep 2021
-
$162.00 K(+6.6%)
$618.00 K(+0.8%)
Jun 2021
-
$152.00 K(-0.7%)
$613.00 K(-0.5%)
Mar 2021
-
$153.00 K(+1.3%)
$616.00 K(-1.1%)
Dec 2020
$623.00 K(+22.2%)
$151.00 K(-3.8%)
$623.00 K(+16.0%)
Sep 2020
-
$157.00 K(+1.3%)
$537.00 K(-4.6%)
Jun 2020
-
$155.00 K(-3.1%)
$562.70 K(+4.8%)
Mar 2020
-
$160.00 K(+146.2%)
$537.00 K(+5.3%)
Dec 2019
$510.00 K
$65.00 K(-64.4%)
$510.00 K(+7.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
$182.70 K(+41.3%)
$475.50 K(+46.2%)
Jun 2019
-
$129.30 K(-2.8%)
$325.20 K(+44.5%)
Mar 2019
-
$133.00 K(+336.1%)
$225.10 K(+81.1%)
Dec 2018
$124.40 K(-25.2%)
$30.50 K(-5.9%)
$124.30 K(-33.3%)
Sep 2018
-
$32.40 K(+11.0%)
$186.30 K(+2.4%)
Jun 2018
-
$29.20 K(-9.3%)
$182.00 K(+2.0%)
Mar 2018
-
$32.20 K(-65.2%)
$178.40 K(+7.3%)
Dec 2017
$166.20 K(+117.3%)
$92.50 K(+229.2%)
$166.20 K(+125.5%)
Sep 2017
-
$28.10 K(+9.8%)
$73.70 K(+61.6%)
Jun 2017
-
$25.60 K(+28.0%)
$45.60 K(+128.0%)
Mar 2017
-
$20.00 K
$20.00 K
Dec 2016
$76.50 K(-2.5%)
-
-
Dec 2015
$78.50 K(-4.7%)
-
-
Dec 2014
$82.40 K(+32.9%)
-
-
Dec 2013
$62.00 K(+26.3%)
-
-
Dec 2012
$49.10 K(+35.3%)
-
-
Dec 2011
$36.30 K(+12.0%)
-
-
Dec 2010
$32.40 K(-9.0%)
-
-
Dec 2009
$35.60 K(+28.1%)
-
-
Dec 2008
$27.80 K(+7.8%)
-
-
Dec 2007
$25.80 K(+561.5%)
-
-
Dec 2006
$3900.00
-
-

FAQ

  • What is Verona Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for Verona Pharma?
  • What is Verona Pharma annual D&A year-on-year change?
  • What is Verona Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Verona Pharma?
  • What is Verona Pharma quarterly D&A year-on-year change?
  • What is Verona Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for Verona Pharma?
  • What is Verona Pharma TTM D&A year-on-year change?

What is Verona Pharma annual depreciation & amortization?

The current annual D&A of VRNA is $1.06 M

What is the all time high annual D&A for Verona Pharma?

Verona Pharma all-time high annual depreciation & amortization is $1.06 M

What is Verona Pharma annual D&A year-on-year change?

Over the past year, VRNA annual depreciation & amortization has changed by +$381.00 K (+56.28%)

What is Verona Pharma quarterly depreciation & amortization?

The current quarterly D&A of VRNA is $259.00 K

What is the all time high quarterly D&A for Verona Pharma?

Verona Pharma all-time high quarterly depreciation & amortization is $270.00 K

What is Verona Pharma quarterly D&A year-on-year change?

Over the past year, VRNA quarterly depreciation & amortization has changed by +$51.00 K (+24.52%)

What is Verona Pharma TTM depreciation & amortization?

The current TTM D&A of VRNA is $1.06 M

What is the all time high TTM D&A for Verona Pharma?

Verona Pharma all-time high TTM depreciation & amortization is $1.06 M

What is Verona Pharma TTM D&A year-on-year change?

Over the past year, VRNA TTM depreciation & amortization has changed by +$381.00 K (+56.28%)